Thomas Nyirenda
Research Subjects
Thomas Nyirenda has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Alimuddin Zumla
Center for Clinical Microbiology, Institute of Infection, Immunity and Transplantation, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK
3 shared publications - David Shu Cheong Hui
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong Special Administrative Region, China
3 shared publications - Moses John Bockarie
School of Community Health Sciences, Njala University, Bo, Sierra Leone
3 shared publications - Christopher da Costa
Coalition for Epidemic Preparedness Innovations, Washington, DC, USA
2 shared publications - Delia Goletti
Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy
2 shared publications - Dorothy Yeboah-Manu
Noguchi Memorial Institute for Medical Research, University of Ghana
2 shared publications
Latest Publications
- Open Access
- 26 February 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 141, 106987
Perspectives on development and advancement of new tuberculosis vaccines
- 26 February 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 141, 106987
Open AccessPerspectives on development and advancement of new tuberculosis vaccines
- Open Access
- 6 April 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 131, 180-182
End of the Bedaquiline patent – a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries
- 6 April 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 131, 180-182
Open AccessEnd of the Bedaquiline patent – a crucial development for moving forward affordable drugs, diagnostics, and vaccines for infectious diseases in low- and middle-income countries
- Open Access
- 14 March 2023
- Published by Elsevier in The Lancet Global Health
- Vol. 11 (4) , e486-E486
Is dropping trial-of-antibiotic treatment in people with suspected tuberculosis enough?
- 14 March 2023
- Published by Elsevier in The Lancet Global Health
- Vol. 11 (4) , e486-E486
Open AccessIs dropping trial-of-antibiotic treatment in people with suspected tuberculosis enough?
- Top Cited PapersOpen Access
- 1 December 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 114, 268-272
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
- 1 December 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 114, 268-272
Top Cited PapersOpen AccessEmergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts
- Open Access
- 1 September 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 110, 54-61
Strengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks
- 1 September 2021
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 110, 54-61
Open AccessStrengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks
- Open Access
- 26 July 2019
- Published by Springer Nature in Globalization and Health
- Vol. 15 (1) , 1-14
Strengthening national health research systems in the WHO African Region – progress towards universal health coverage
Health challenges and health systems set-ups differ, warranting contextualised healthcare interventions to move towards universal health coverage. As such, there is emphasis on generation of contextualized evidence to solve local challenges. However, weak research capacity and inadequate resources remain an impendiment to quality research in the African region. WHO African Region (WHO AFR) facilitated the adoption of a regional strategy for strengthening national health research systems (NHRS) in 2015. We assessed the progress in strengthening NHRS among the 47 member states of the WHO AFR. We employed a cross sectional survey design using a semi structured questionnaire. All the 47member states of WHO AFR were surveyed. We assessed performance against indicators of the regional research strategy, explored facilitating factors and barriers to strengthening NHRS. Using the research barometer, which is a metric developed for the WHO AFR we assessed the strength of NHRS of member states. Data were analysed in Excel Software to calculate barometer scores for NHRS function and sub-function. Thematic content was employed in analysing the qualitative data. Data for 2014 were compared to 2018 to assess progress. WHO AFR member states have made significant progress in strengthening their NHRS. Some of the indicators have either attained or exceeded the 2025 targets. The average regional barometer score improved from 43% in 2014 to 61% in 2018. Significant improvements were registered in the governance of research for health (R4H); developing and sustaining research resources and producing and using research. Financing R4H improved only modestly. Among the constraints are the lengthy ethical clearance processes, weak research coordination mechanisms, weak enforcement of research laws and regulation, inadequate research infrastructure, limited resource mobilisation skills and donor dependence. There has been significant improvement in the NHRS of member states of the WHO AFRO since the last assessment in 2014. Improvement across the different objectives of the regional research strategy is however varied which compromises overall performance. The survey highlighted the areas with slow improvement that require a concerted effort. Furthermore, the study provides an opportunity for countries to share best practice in areas of excellence.
- 26 July 2019
- Published by Springer Nature in Globalization and Health
- Vol. 15 (1) , 1-14
Open AccessStrengthening national health research systems in the WHO African Region – progress towards universal health coverage
Health challenges and health systems set-ups differ, warranting contextualised healthcare interventions to move towards universal health coverage. As such, there is emphasis on generation of contextualized evidence to solve local challenges. However, weak research capacity and inadequate resources remain an impendiment to quality research in the African region. WHO African Region (WHO AFR) facilitated the adoption of a regional strategy for strengthening national health research systems (NHRS) in 2015. We assessed the progress in strengthening NHRS among the 47 member states of the WHO AFR. We employed a cross sectional survey design using a semi structured questionnaire. All the 47member states of WHO AFR were surveyed. We assessed performance against indicators of the regional research strategy, explored facilitating factors and barriers to strengthening NHRS. Using the research barometer, which is a metric developed for the WHO AFR we assessed the strength of NHRS of member states. Data were analysed in Excel Software to calculate barometer scores for NHRS function and sub-function. Thematic content was employed in analysing the qualitative data. Data for 2014 were compared to 2018 to assess progress. WHO AFR member states have made significant progress in strengthening their NHRS. Some of the indicators have either attained or exceeded the 2025 targets. The average regional barometer score improved from 43% in 2014 to 61% in 2018. Significant improvements were registered in the governance of research for health (R4H); developing and sustaining research resources and producing and using research. Financing R4H improved only modestly. Among the constraints are the lengthy ethical clearance processes, weak research coordination mechanisms, weak enforcement of research laws and regulation, inadequate research infrastructure, limited resource mobilisation skills and donor dependence. There has been significant improvement in the NHRS of member states of the WHO AFRO since the last assessment in 2014. Improvement across the different objectives of the regional research strategy is however varied which compromises overall performance. The survey highlighted the areas with slow improvement that require a concerted effort. Furthermore, the study provides an opportunity for countries to share best practice in areas of excellence.
- Open Access
- 31 July 2018
- Published by Springer Nature in Globalization and Health
- Vol. 14 (1) , 1-10
Strengthening health research capacity in sub-Saharan Africa: mapping the 2012–2017 landscape of externally funded international postgraduate training at institutions in the region
The objective was to guide key stakeholders on future directions of external funding of international postgraduate training (Master’s and PhD) of health research students at institutions in sub-Saharan Africa by mapping the numbers and characteristics of students, the location of institutions, and sources of external support. A cross-sectional survey of eligible external funding organizations and programmes was conducted in 2017. Information was gathered from funders’ websites or through the assistance of institutional contacts. The information requested included the number of Master’s and PhD grantees supported from January 2012 to June 2017, as well as each grantee’s institution of study, gender, country of origin and research area. Of 72 organizations contacted, there were 44 responses. Of the 44, 30 funders reported programmes within the inclusion criteria, and 19 funders provided data on relevant programmes. The Wellcome Trust, the International Development Research Centre and the Norwegian Agency for Development Cooperation supported the greatest number of grantees. There was concentrated support for grantees in eastern and southern Africa, countries with developed research capacity, and highly-developed research and training centres. More support was provided for PhD than Master’s degree programmes and for research areas more upstream along the research spectrum. Challenges were identified in recognizing relevant funding organizations and obtaining responses. Information was presented inconsistently across organizations, which were often unable to provide relevant and complete data within the survey timeframe. External funders should collect, analyse and report data at regular intervals on their support for strengthening postgraduate health research capacity in sub-Saharan Africa. Standardization of this process and development of an online database would not only help to avoid overlap between programmes and promote synergy between funders, but also inform dialogue between external funders and key stakeholders on strategic issues. These issues include how external funders can a) optimise their support for research capacity strengthening to maximise the benefits of research for health and development on an equitable basis, and b) optimise the distribution of support for researchers at different career stages and for research on different parts of the research spectrum to maximise the health benefits of research.
- 31 July 2018
- Published by Springer Nature in Globalization and Health
- Vol. 14 (1) , 1-10
Open AccessStrengthening health research capacity in sub-Saharan Africa: mapping the 2012–2017 landscape of externally funded international postgraduate training at institutions in the region
The objective was to guide key stakeholders on future directions of external funding of international postgraduate training (Master’s and PhD) of health research students at institutions in sub-Saharan Africa by mapping the numbers and characteristics of students, the location of institutions, and sources of external support. A cross-sectional survey of eligible external funding organizations and programmes was conducted in 2017. Information was gathered from funders’ websites or through the assistance of institutional contacts. The information requested included the number of Master’s and PhD grantees supported from January 2012 to June 2017, as well as each grantee’s institution of study, gender, country of origin and research area. Of 72 organizations contacted, there were 44 responses. Of the 44, 30 funders reported programmes within the inclusion criteria, and 19 funders provided data on relevant programmes. The Wellcome Trust, the International Development Research Centre and the Norwegian Agency for Development Cooperation supported the greatest number of grantees. There was concentrated support for grantees in eastern and southern Africa, countries with developed research capacity, and highly-developed research and training centres. More support was provided for PhD than Master’s degree programmes and for research areas more upstream along the research spectrum. Challenges were identified in recognizing relevant funding organizations and obtaining responses. Information was presented inconsistently across organizations, which were often unable to provide relevant and complete data within the survey timeframe. External funders should collect, analyse and report data at regular intervals on their support for strengthening postgraduate health research capacity in sub-Saharan Africa. Standardization of this process and development of an online database would not only help to avoid overlap between programmes and promote synergy between funders, but also inform dialogue between external funders and key stakeholders on strategic issues. These issues include how external funders can a) optimise their support for research capacity strengthening to maximise the benefits of research for health and development on an equitable basis, and b) optimise the distribution of support for researchers at different career stages and for research on different parts of the research spectrum to maximise the health benefits of research.
- Open Access
- 24 August 2017
- Published by Juniper Publishers in Global Journal of Otolaryngology
- Vol. 10 (1)
Strategies to combat ear and hearing disorders in a poor African country, the Malawi National Plan
- 24 August 2017
- Published by Juniper Publishers in Global Journal of Otolaryngology
- Vol. 10 (1)
Open AccessStrategies to combat ear and hearing disorders in a poor African country, the Malawi National Plan
- 25 February 2014
- Published by SAGE Publications in Tropical Doctor
- Vol. 44 (3) , 135-139
Initiating and developing clinical services, training and research in a low resource setting: the Malawi ENT experience
Background: Sub-Saharan Africa countries like Malawi have a paucity of ear, nose and throat (ENT) data, services and training opportunities. Objective: To reflect on new Malawian ENT experience and to propose guidelines to poorly resourced countries. Design: Analysis of data predating and following establishment of ENT services in Malawi. Results: In 2008 the first and only Malawian ENT specialist established ENT services with external funding. Fifteen clinical officers have been trained and a nurse placed at each outreach hospital. In 2012, 15,284 consultations were recorded: 543 (3.6%) from outreach clinics. Forty-nine percent needed medical treatment, while 45% needed medical advice. Surgery was performed on 2.7% of patients; 21% for foreign bodies in the nose and throat and 18% for foreign bodies and biopsies of ears. Conclusions: To establish accessible and sustainable specialist ENT services in a poor country requires building on an established local health delivery system, careful planning and investment in personnel, infrastructure, training and data collection.
- 25 February 2014
- Published by SAGE Publications in Tropical Doctor
- Vol. 44 (3) , 135-139
Initiating and developing clinical services, training and research in a low resource setting: the Malawi ENT experience
Background: Sub-Saharan Africa countries like Malawi have a paucity of ear, nose and throat (ENT) data, services and training opportunities. Objective: To reflect on new Malawian ENT experience and to propose guidelines to poorly resourced countries. Design: Analysis of data predating and following establishment of ENT services in Malawi. Results: In 2008 the first and only Malawian ENT specialist established ENT services with external funding. Fifteen clinical officers have been trained and a nurse placed at each outreach hospital. In 2012, 15,284 consultations were recorded: 543 (3.6%) from outreach clinics. Forty-nine percent needed medical treatment, while 45% needed medical advice. Surgery was performed on 2.7% of patients; 21% for foreign bodies in the nose and throat and 18% for foreign bodies and biopsies of ears. Conclusions: To establish accessible and sustainable specialist ENT services in a poor country requires building on an established local health delivery system, careful planning and investment in personnel, infrastructure, training and data collection.
- Open Access
- 20 July 2009
- Published by Springer Nature in BMC Public Health
- Vol. 9 (1) , 249
European and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership
European and Developing Countries Clinical Trials Partnership (EDCTP) was founded in 2003 by the European Parliament and Council. It is a partnership of 14 European Union (EU) member states, Norway, Switzerland, and Developing Countries, formed to fund acceleration of new clinical trial interventions to fight the human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS), malaria and tuberculosis (TB) in the sub-Saharan African region. EDCTP seeks to be synergistic with other funding bodies supporting research on these diseases.
- 20 July 2009
- Published by Springer Nature in BMC Public Health
- Vol. 9 (1) , 249
Open AccessEuropean and Developing Countries Clinical Trials Partnership (EDCTP): the path towards a true partnership
European and Developing Countries Clinical Trials Partnership (EDCTP) was founded in 2003 by the European Parliament and Council. It is a partnership of 14 European Union (EU) member states, Norway, Switzerland, and Developing Countries, formed to fund acceleration of new clinical trial interventions to fight the human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS), malaria and tuberculosis (TB) in the sub-Saharan African region. EDCTP seeks to be synergistic with other funding bodies supporting research on these diseases.